High-Dose Dual Therapy Versus Bismuth Quadruple Therapy for Rescue Treatment of Helicobacter pylori: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Abstract
Background/Aims: Failure of first-line Helicobacter pylori (HP) eradication therapy occurs in approximately 3%-24% of patients. Highdose dual therapy (HDDT) has been proposed as an alternative rescue regimen. This meta analysis compared the efficacy and safety of HDDT and bismuth-containing quadruple therapy (BQT) in patients undergoing rescue eradication therapy. Materials and Methods: Randomized controlled trials (RCTs) comparing HDDT with BQT for HP rescue therapy were systematically searched in multiple databases from January 1, 2000, to June 30, 2025. Primary outcomes were eradication rates based on intention-totreat (ITT) and per-protocol (PP) analyses. Secondary outcomes included treatment compliance and adverse events. Statistical analyses were performed using Stata 18.0 and RevMan 5.4. Results: Ten RCTs involving 2458 patients were included. In the ITT analysis, HP eradication rates were comparable between the HDDT and BQT groups (81.09% vs. 80.02%, relative risk (RR) = 1.01, 95% CI: 0.97-1.05, P = .54). Similarly, no significant difference was observed in the PP analysis (86.42% vs. 86.27%, RR = 1.00, 95% CI: 0.97-1.03, P = .90). However, HDDT was associated with significantly lower incidence of adverse events (14.00% vs. 35.13%, RR = 0.40, 95% CI: 0.31-0.51, P < .00001) and higher patient compliance (92.75% vs. 88.62%, RR = 1.08, 95% CI: 1.01-1.14, P = .02) compared with BQT. Conclusion: HDDT achieved eradication rates comparable to those of BQT for rescue therapy…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 2,458 participants or records.
Read the paper
Related studies
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
- Occupation and risk of severe COVID-19: prospective cohort study of 120,075 UK Biobank participants
- Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study
- Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study
- Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study of 387,109 adults in UK
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.